Nisa Investment Advisors
KRTX

Nisa Investment Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nisa Investment Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-275
Closed -$87K – 2829
2023
Q4 		$87K Sell
275
-265
-49% -$51.5K ﹤0.01% 1474
2023
Q3 		$91.3K Sell
540
-8,488
-94% -$1.6M ﹤0.01% 1533
2023
Q2 		$1.96M Buy
9,028
+8,223
+1,021% +$1.76M 0.01% 679
2023
Q1 		$146K Buy
805
+10
+1% +$1.91K ﹤0.01% 1382
2022
Q4 		$156K Hold
795
– – ﹤0.01% 1418
2022
Q3 		$174K Buy
795
+29
+4% +$5.87K ﹤0.01% 1308
2022
Q2 		$97K Buy
766
+80
+12% +$9.19K ﹤0.01% 1521
2022
Q1 		$87K Sell
686
-556
-45% -$62.6K ﹤0.01% 1672
2021
Q4 		$138K Buy
1,242
+217
+21% +$28K ﹤0.01% 1398
2021
Q3 		$125 Buy
1,025
+75
+8% +$8.66K ﹤0.01% 1602
2021
Q2 		$108 Hold
950
– – ﹤0.01% 1653
2021
Q1 		$114 Hold
950
– – ﹤0.01% 1699
2020
Q4 		$97K Buy
950
+300
+46% +$27.8K ﹤0.01% 1742
2020
Q3 		$50K Buy
+650
New +$55.4K ﹤0.01% 1812

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nisa Investment Advisors's KRTX Position: Q1 2024 in Review

Nisa Investment Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 275 shares — an estimated $87K sold.

Nisa Investment Advisors first reported a position in KRTX in Q3 2020 and held it in 14 quarters. The position peaked at $1.96M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Nisa Investment Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 275 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $87K.
  • Nisa Investment Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Nisa Investment Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $1.96M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Nisa Investment Advisors's 13F filing for Q1 2024, filed 2 May 2024.